HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Qin Wang Selected Research

ML216

12/2021BLM helicase inhibition synergizes with PARP inhibition to improve the radiosensitivity of olaparib resistant non-small cell lung cancer cells by inhibiting homologous recombination repair.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Qin Wang Research Topics

Disease

253Neoplasms (Cancer)
12/2022 - 06/2002
107Breast Neoplasms (Breast Cancer)
10/2022 - 03/2003
66Inflammation (Inflammations)
05/2022 - 10/2005
45Infections
09/2022 - 07/2003
31Neoplasm Metastasis (Metastasis)
06/2022 - 08/2007
30Hepatocellular Carcinoma (Hepatoma)
01/2022 - 08/2003
22Carcinogenesis
02/2022 - 08/2003
21Lung Neoplasms (Lung Cancer)
01/2022 - 09/2009
20Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2022 - 09/2009
18Glioma (Gliomas)
01/2022 - 03/2006
17Cognitive Dysfunction
01/2022 - 04/2008
17Fibrosis (Cirrhosis)
01/2022 - 11/2009
17Colorectal Neoplasms (Colorectal Cancer)
11/2021 - 12/2008
16Rheumatoid Arthritis
01/2022 - 12/2004
15Prostatic Neoplasms (Prostate Cancer)
09/2019 - 01/2002
14Ovarian Neoplasms (Ovarian Cancer)
01/2022 - 08/2007
14Melanoma (Melanoma, Malignant)
07/2021 - 08/2007
12Wounds and Injuries (Trauma)
09/2022 - 03/2010
12Hypoxia (Hypoxemia)
01/2022 - 08/2008
12Alzheimer Disease (Alzheimer's Disease)
01/2022 - 04/2005
12Carcinoma (Carcinomatosis)
04/2020 - 06/2002
11Uterine Cervical Neoplasms (Cancer of the Cervix)
01/2022 - 05/2012
11Arthritis (Polyarthritis)
01/2022 - 12/2004
11Insulin Resistance
01/2022 - 10/2005
11COVID-19
01/2022 - 01/2020
11Chronic Obstructive Pulmonary Disease (COPD)
01/2021 - 06/2013
10Chronic Kidney Failure (Chronic Renal Failure)
08/2022 - 10/2010
10Cardiovascular Diseases (Cardiovascular Disease)
03/2022 - 10/2006
10Body Weight (Weight, Body)
06/2021 - 11/2006
10Necrosis
03/2021 - 10/2013
9Hepatitis B
06/2022 - 06/2012
9Stomach Neoplasms (Stomach Cancer)
06/2022 - 01/2014
9Obesity
02/2022 - 05/2015
9Liver Cirrhosis (Hepatic Cirrhosis)
06/2021 - 11/2013
9Hypertension (High Blood Pressure)
01/2021 - 05/2009
9Chronic Renal Insufficiency
10/2020 - 12/2007
9Neuroblastoma
10/2020 - 07/2009
8IGA Glomerulonephritis (IGA Nephropathy)
01/2022 - 01/2012
8Reperfusion Injury
11/2021 - 03/2014
8Atherosclerosis
09/2021 - 01/2007
8Acute Lung Injury
01/2021 - 03/2014
8Acute Kidney Injury (Acute Renal Failure)
01/2021 - 04/2014
8Type 2 Diabetes Mellitus (MODY)
01/2021 - 01/2013
8Myocardial Infarction
12/2020 - 10/2006
8Proteinuria
10/2020 - 03/2010
7Multiple Sclerosis
05/2022 - 11/2011
7Pneumonia (Pneumonitis)
01/2021 - 12/2002
7Pain (Aches)
04/2020 - 03/2012

Drug/Important Bio-Agent (IBA)

99Proteins (Proteins, Gene)FDA Link
10/2022 - 02/2005
40Estrogen ReceptorsIBA
10/2022 - 10/2011
36Pharmaceutical PreparationsIBA
10/2022 - 07/2003
35Biomarkers (Surrogate Marker)IBA
08/2022 - 02/2005
31Biological ProductsIBA
01/2022 - 02/2006
27Messenger RNA (mRNA)IBA
04/2022 - 12/2002
25DNA (Deoxyribonucleic Acid)IBA
05/2022 - 08/2007
24CytokinesIBA
06/2022 - 09/2004
21Therapeutic UsesIBA
09/2022 - 12/2005
21RNA (Ribonucleic Acid)IBA
01/2022 - 01/2009
21MicroRNAs (MicroRNA)IBA
01/2022 - 03/2011
19Hormones (Hormone)IBA
01/2022 - 08/2008
18Long Noncoding RNAIBA
04/2022 - 07/2017
16Small Interfering RNA (siRNA)IBA
01/2021 - 04/2012
15LipidsIBA
01/2021 - 01/2014
14Cisplatin (Platino)FDA LinkGeneric
08/2020 - 04/2012
12Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
04/2022 - 09/2009
12IronIBA
12/2021 - 03/2006
12VaccinesIBA
10/2021 - 10/2008
11CateninsIBA
05/2022 - 01/2014
11EnzymesIBA
02/2022 - 05/2002
11Insulin (Novolin)FDA Link
01/2022 - 10/2005
11AcidsIBA
06/2021 - 08/2010
11AntigensIBA
03/2021 - 12/2008
11Phosphotransferases (Kinase)IBA
01/2021 - 09/2007
10AntioxidantsIBA
06/2022 - 09/2010
10Peptides (Polypeptides)IBA
01/2022 - 05/2005
10Transcription Factors (Transcription Factor)IBA
11/2021 - 09/2007
10Glucose (Dextrose)FDA LinkGeneric
01/2021 - 10/2005
9Interleukin-6 (Interleukin 6)IBA
04/2022 - 01/2008
9Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
04/2022 - 12/2004
9Progesterone Receptors (Progesterone Receptor)IBA
03/2022 - 10/2011
8AlbuminsIBA
02/2021 - 03/2003
8Indicators and Reagents (Reagents)IBA
01/2021 - 12/2008
8LipopolysaccharidesIBA
12/2020 - 09/2007
8Monoclonal AntibodiesIBA
12/2018 - 08/2007
7InterferonsIBA
06/2022 - 01/2016
7CreatinineIBA
02/2022 - 01/2012
7Reactive Oxygen Species (Oxygen Radicals)IBA
01/2022 - 09/2010
7Anti-Bacterial Agents (Antibiotics)IBA
01/2022 - 10/2011
7Antiviral Agents (Antivirals)IBA
01/2022 - 07/2009
7InflammasomesIBA
10/2021 - 10/2016
7AntibodiesIBA
06/2021 - 04/2003
7SmokeIBA
01/2021 - 05/2011
6HydrogelsIBA
09/2022 - 03/2006

Therapy/Procedure

106Therapeutics
08/2022 - 03/2003
35Drug Therapy (Chemotherapy)
06/2022 - 04/2011
28Radiotherapy
01/2022 - 03/2003
23Immunotherapy
01/2022 - 04/2003
19Peritoneal Dialysis
08/2022 - 03/2003
7Ligation
01/2022 - 05/2010
7Aftercare (After-Treatment)
01/2021 - 06/2011